Northern Trust’s Harmony Biosciences HRMY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $13.7M | Buy |
433,935
+30,393
| +8% | +$960K | ﹤0.01% | 1883 |
|
|
2025
Q1 | $13.4M | Sell |
403,542
-920
| -0.2% | -$30.5K | ﹤0.01% | 1871 |
|
|
2024
Q4 | $13.9M | Buy |
404,462
+110,345
| +38% | +$3.8M | ﹤0.01% | 1934 |
|
|
2024
Q3 | $11.8M | Sell |
294,117
-13,151
| -4% | -$526K | ﹤0.01% | 1971 |
|
|
2024
Q2 | $9.27M | Sell |
307,268
-16,246
| -5% | -$490K | ﹤0.01% | 2037 |
|
|
2024
Q1 | $10.9M | Sell |
323,514
-8,002
| -2% | -$269K | ﹤0.01% | 1985 |
|
|
2023
Q4 | $10.7M | Sell |
331,516
-12,795
| -4% | -$413K | ﹤0.01% | 2020 |
|
|
2023
Q3 | $11.3M | Buy |
344,311
+12,027
| +4% | +$394K | ﹤0.01% | 1912 |
|
|
2023
Q2 | $11.7M | Buy |
332,284
+58,018
| +21% | +$2.04M | ﹤0.01% | 1943 |
|
|
2023
Q1 | $8.95M | Sell |
274,266
-588
| -0.2% | -$19.2K | ﹤0.01% | 2093 |
|
|
2022
Q4 | $15.1M | Buy |
274,854
+5,837
| +2% | +$322K | ﹤0.01% | 1727 |
|
|
2022
Q3 | $11.9M | Buy |
269,017
+14,487
| +6% | +$642K | ﹤0.01% | 1859 |
|
|
2022
Q2 | $12.4M | Buy |
254,530
+21,396
| +9% | +$1.04M | ﹤0.01% | 1866 |
|
|
2022
Q1 | $11.3M | Sell |
233,134
-7,690
| -3% | -$374K | ﹤0.01% | 2070 |
|
|
2021
Q4 | $10.3M | Buy |
240,824
+28,516
| +13% | +$1.22M | ﹤0.01% | 2213 |
|
|
2021
Q3 | $8.14M | Buy |
212,308
+22,187
| +12% | +$850K | ﹤0.01% | 2431 |
|
|
2021
Q2 | $5.37M | Buy |
190,121
+121,335
| +176% | +$3.43M | ﹤0.01% | 2798 |
|
|
2021
Q1 | $2.27M | Sell |
68,786
-5,427
| -7% | -$179K | ﹤0.01% | 3172 |
|
|
2020
Q4 | $2.68M | Buy |
+74,213
| New | +$2.68M | ﹤0.01% | 3041 |
|